DISCOVERY OF A NOVEL, POTENTIAL FIRST‐IN‐CLASS MALT1 PROTEASE INHIBITOR FOR THE TREATMENT OF B CELL LYMPHOMAS.

Autor:	Philippar, U., Lu, T., Vloemans, N., Bekkers, M., Nuffel, L., Gaudiano, M., Wnuk‐Lipinska, K., Van Der Leede, B., Amssoms, K., Kimpe, K., Medaer, B., Greway, T., Abraham, Y., Cummings, M., Trella, E., Vanhoof, G., Sun, W., Thuring, J., Connolly, P., Linders, J.
Předmět:	ANAPLASTIC lymphoma kinase MUCOSA-associated lymphoid tissue lymphoma B cells PROTEASE inhibitors HIV protease inhibitors THERAPEUTICS
Zdroj:	Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p128-128, 1p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text